Previous 10 | Next 10 |
The psilocybin mushroom story isn’t likely peak any time soon. Over the last few months, Denver, Oakland, and Santa Cruz just decriminalized the possession of products containing psilocybin or psilocin. Washington, D.C. could be next. Major institutions are even studying its use for ...
Consumer interest in CBD is off the charts. Research shows that Google searches about CBD number some 6.4 million unique searches every month, according to U.S. News & World Report . That equals or surpasses interest in any other healthcare issue, product or topic. CBD consumer interest i...
The CBD industry is growing exponentially and projected by search firms to grow 125% YOY each year for next five years. To grow in market share in an exploding industry requires an ability to grow in omni channels, in new foreign markets and in diverse classifications, from oils to pets. ...
With Canada and the U.S. dominating the cannabis industry , investors who are involved with marijuana stocks are waiting for another potential green rush. Right now the industries focus is on the U.S. and Canada. These are the two areas of the world with broad legislation and booming industri...
LONDON and CARLSBAD, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid pro...
GW Pharmaceuticals (NASDAQ: GWPH) hit paydirt when its crown jewel -- Epidiolex -- became the first cannabidiol-derived drug approved by the U.S. Food and Drug Administration (FDA). Epidiolex is a treatment for seizures in patients with Lennox-Gastaut syndrome (LGS) and Dravet syndrome, both...
As marijuana stocks work to bounce back in the market the cannabis industry as a whole is building off new momentum. This slow but steady progress has the potential to help rebuild from the 2019 downtrend. Though 2020 is off to a similar start, some uptrends have started to take place in the c...
Denver, Colorado, Oakland, California, and most recently Santa Cruz City decriminalized the possession of products containing psilocybin or psilocin. D.C. may join those cities this November 2020. In fact, according to The Washington Post , the D.C. Board of Elections decided that the propos...
CBD consumers are tantalizingly close. More than 40% of consumers aged 21 and above say they would consider trying CBD. The question is: how to close that sale and retain loyal customers for repeat business. The answer is that CBD marketing needs to be sophisticated to achieve effective omni-c...
As the CBD pet market skyrockets to $1.7 billion by 2023, as projected by Brightfield Group, CBD companies that focus on this market are seeing opportunities selling to owners of pets, such as horses, cats and dogs. Offering a variety of pet chews, oils and equine products, CBD Unlimited, Inc....
News, Short Squeeze, Breakout and More Instantly...
GW Pharmaceuticals Plc Company Name:
GWPH Stock Symbol:
NASDAQ Market:
GW Pharmaceuticals Plc Website:
The key to investing is “Buy low, sell high”. According to that mantra, periods of weakness are the mother’s milk of future gains. When you see them, you know “this is my chance”. It’s the chance to get involved. This is especially true in industries ...
NetworkNewsWire Editorial Coverage : In May 2013, GW Pharma listed on Nasdaq, selling 3.5 million shares at $8.90 each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds. Legal cannabis was only beginning to gain...
Real Brands Inc (OTCMKTS:RLBD) snuck one under the radar late last week, but investors interested in the CBD and Cannabis space should take note. The company filed its Form 10 with the SEC. In this case, it was a voluntary filing because the company does report having over $10 million o...